American International Group, Inc. Bio Xcel Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.95 - $4.04 $452 - $937	232 Added 2.3%	10,315 $29,000
Q4 2023 Feb 13, 2024	SELL	$2.32 - $5.51 $97 - $231	-42 Reduced 0.41%	10,083 $29,000
Q3 2023 Nov 13, 2023	BUY	$2.49 - $11.85 $2,221 - $10,570	892 Added 9.66%	10,125 $25,000
Q2 2023 Aug 04, 2023	BUY	$6.39 - $28.58 $19 - $85	3 Added 0.03%	9,233 $61,000
Q1 2023 May 12, 2023	BUY	$17.7 - $33.24 $3,256 - $6,116	184 Added 2.03%	9,230 $172,000
Q4 2022 Feb 10, 2023	SELL	$10.25 - $22.43 $338 - $740	-33 Reduced 0.36%	9,046 $194,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $1,432 - $2,289	128 Added 1.43%	9,079 $107,000
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $3,521 - $8,404	390 Added 4.56%	8,951 $118,000
Q1 2022 May 13, 2022	SELL	$15.0 - $22.83 $9,030 - $13,743	-602 Reduced 6.57%	8,561 $179,000
Q4 2021 Feb 11, 2022	SELL	$20.12 - $35.09 $5,512 - $9,614	-274 Reduced 2.9%	9,163 $186,000
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $20,812 - $27,962	873 Added 10.19%	9,437 $286,000
Q2 2021 Aug 13, 2021	BUY	$29.06 - $38.83 $32,430 - $43,334	1,116 Added 14.98%	8,564 $249,000
Q1 2021 May 07, 2021	BUY	$39.04 - $64.6 $741 - $1,227	19 Added 0.26%	7,448 $321,000
Q4 2020 Feb 12, 2021	BUY	$42.46 - $56.58 $17,790 - $23,707	419 Added 5.98%	7,429 $343,000
Q3 2020 Nov 04, 2020	BUY	$37.44 - $64.63 $20,105 - $34,706	537 Added 8.3%	7,010 $304,000
Q2 2020 Aug 12, 2020	BUY	$17.62 - $58.71 $41,653 - $138,790	2,364 Added 57.53%	6,473 $343,000
Q1 2020 May 04, 2020	SELL	$12.26 - $41.14 $2,905 - $9,750	-237 Reduced 5.45%	4,109 $92,000
Q4 2019 Feb 05, 2020	BUY	$4.05 - $14.61 $2,182 - $7,874	539 Added 14.16%	4,346 $63,000
Q3 2019 Nov 08, 2019	SELL	$7.04 - $11.77 $183 - $306	-26 Reduced 0.68%	3,807 $27,000
Q2 2019 Aug 13, 2019	BUY	$8.99 - $11.79 $34,458 - $45,191	3,833 New	3,833 $42,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.26M

Call Options Held

101K

Put Options Held

205K

Armistice Capital, LLC New York, NY

2.99M
Shares

$1.79 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

970K
Shares

$582,258
0.0% of portfolio
Black Rock Inc. New York, NY

441K
Shares

$264,411
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

267K
Shares

$160,031
0.0% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

204K
Shares

$122,169
0.0% of portfolio

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $16.8M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account